Memory Enhancement in Aging With Optimal Dosing
Boston University Charles River Campus · NCT07461584
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 65+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 240
- US sites recruiting
- 1
- Study start
- June 1, 2026
- Record last updated
- July 22, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This project optimizes high-resolution transcranial Alternating Current Stimulation (tACS) to improve memory in healthy older adults, advancing drug-free approaches for Alzheimer's disease and related dementia (ADRD). We test stimulation schedules and develop an adaptive, brain-guided tACS system to strengthen memory-supporting networks.
Being studied: 1-day patterned tACS; 3-day patterned tACS; 5-day patterned tACS; 1-day continuous tACS; 3-day continuous tACS; 5-day continuous tACS
Conditions: Aging; Noninvasive Brain Stimulation; Memory
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 65 years of age or older
- normal or corrected-to-normal vision
- color vision
Exclusion Criteria
- pregnant
- metal implants in head
- implanted electronic devices
- history of neurological problems or head injury
- skin sensitivity
- claustrophobia
- dementia (normal Montreal Cognitive Assessment > 25)
- depression (normal Geriatric Depression Scale \< 10)
- history of psychosis
- cognitive deficits (MoCA>25)
- any psychoactive medication
Recruiting US locations
111 Cummington Mall
Boston, MA 02215
Site contact: Robert Reinhart, PhD · 617-353-9481 · rmgr@bu.edu
Study contacts (from the official record)
- Robert Reinhart, PhD · (617) 353-9481 · rmgr@bu.edu
Similar studies in Massachusetts
All healthy volunteers studies in Massachusetts →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Boston, MA + 49 other US sites
- Eligibility basics
- Ages 60+